ES1311367U - OINTMENT PRODUCT FOR BRUISES (Machine-translation by Google Translate, not legally binding) - Google Patents
OINTMENT PRODUCT FOR BRUISES (Machine-translation by Google Translate, not legally binding) Download PDFInfo
- Publication number
- ES1311367U ES1311367U ES202430499U ES202430499U ES1311367U ES 1311367 U ES1311367 U ES 1311367U ES 202430499 U ES202430499 U ES 202430499U ES 202430499 U ES202430499 U ES 202430499U ES 1311367 U ES1311367 U ES 1311367U
- Authority
- ES
- Spain
- Prior art keywords
- bruises
- ointment product
- ointment
- translation
- machine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000034656 Contusions Diseases 0.000 title claims abstract description 14
- 239000002674 ointment Substances 0.000 title claims abstract description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims abstract description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229940099259 vaseline Drugs 0.000 claims abstract description 9
- 239000000787 lecithin Substances 0.000 claims abstract description 8
- 235000010445 lecithin Nutrition 0.000 claims abstract description 8
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 7
- 108010007979 Glycocholic Acid Proteins 0.000 claims abstract description 7
- RFDAIACWWDREDC-UHFFFAOYSA-N Na salt-Glycocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 RFDAIACWWDREDC-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229940099347 glycocholic acid Drugs 0.000 claims abstract description 7
- RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 claims abstract description 7
- 229940067606 lecithin Drugs 0.000 claims abstract description 7
- 235000019175 phylloquinone Nutrition 0.000 claims abstract description 7
- 239000011772 phylloquinone Substances 0.000 claims abstract description 7
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 claims abstract description 7
- 229960001898 phytomenadione Drugs 0.000 claims abstract description 7
- 239000008223 sterile water Substances 0.000 claims abstract description 7
- 238000011109 contamination Methods 0.000 claims abstract description 4
- 229940083608 sodium hydroxide Drugs 0.000 claims abstract description 3
- 239000000047 product Substances 0.000 description 7
- 208000034526 bruise Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940100615 topical ointment Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Producto en pomada para hematomas, caracterizado porque su fórmula contiene: fitomenadiona, ácido glicocólico, hidróxido de sodio, lecitina, ácido clorhídrico al 25%, agua estéril sin contaminación y vaselina pura filante.Ointment product for bruises, characterized by its formula containing: phytomenadione, glycocholic acid, sodium hydroxide, lecithin, 25% hydrochloric acid, sterile water without contamination and pure threading Vaseline.
Description
DESCRIPCIÓN DESCRIPTION
PRODUCTO EN POMADA PARA HEMATOMAS OINTMENT PRODUCT FOR BRUISES
OBJETO DE LA INVENCIÓN OBJECT OF THE INVENTION
La invención se refiere, tal como expresa el enunciado de la presente memoria descriptiva, a un producto en pomada para hematomas, que acelera el proceso de decoloración de los hematomas y rojeces desde su primer uso, que aporta, a la función a que se destina, ventajas y características, que se describen en detalle más adelante y que suponen una mejora al estado actual de la técnica. Más en particular, el objeto de la invención se centra en una composición de aplicación tópica que, comprendiendo al menos un vehículo absorbente, como la vaselina, y entre otros ingredientes una fórmula de vitamina K líquida, sirviendo, entre otras aplicaciones a minimizar y normalizar las pigmentaciones antiestéticas de la piel, de color amarillo parduzco o verdosos producidos por un hematoma que aparece en la piel por un golpe, lesión o inyección que afecta a los vasos sanguíneos produciendo un derrame de sangre bajo la piel, lo que causa esas manchas de color morado y posteriormente verdes o marrones. The invention relates, as expressed in the title of this specification, to an ointment product for bruises, which accelerates the process of discolouration of bruises and redness from the first use, which provides, to the function for which it is intended, advantages and characteristics, which are described in detail below and which represent an improvement on the current state of the art. More particularly, the object of the invention focuses on a composition for topical application that, comprising at least one absorbent vehicle, such as Vaseline, and among other ingredients a liquid vitamin K formula, serving, among other applications, to minimise and normalise unsightly skin pigmentations, of a brownish-yellow or greenish colour produced by a bruise that appears on the skin due to a blow, injury or injection that affects the blood vessels producing a blood spill under the skin, which causes those purple and later green or brown spots.
CAMPO DE APLICACIÓN FIELD OF APPLICATION
El campo de aplicación de la presente invención se enmarca dentro del sector de la industria dedicada a la fabricación de productos cosméticos, y más concretamente en el campo de la elaboración de preparados para el tratamiento de la piel humana. The field of application of the present invention is within the sector of the industry dedicated to the manufacture of cosmetic products, and more specifically in the field of the development of preparations for the treatment of human skin.
ANTECEDENTES DE LA INVENCIÓN BACKGROUND OF THE INVENTION
Como referencia al estado actual de la técnica, cabe señalar que, al menos por parte del solicitante, se desconoce la existencia de fórmulas de aplicación tópica que combinen los principios activos o elementos que comprende la que aquí se preconiza, según se revindica. Existen productos en el mercado para tratar y aliviar los síntomas de un hematoma, y algunos con vitamina, K, ya que es un nutriente esencial, pero el que se preconiza acelera la desaparición de esos molestos moretones en la piel en la mitad de tiempo que cualquier ungüento o pomada existente. As a reference to the current state of the art, it should be noted that, at least on the part of the applicant, the existence of topical application formulas that combine the active ingredients or elements that comprise the one recommended here, as claimed, is unknown. There are products on the market to treat and relieve the symptoms of a bruise, and some with vitamin K, since it is an essential nutrient, but the one recommended accelerates the disappearance of those annoying bruises on the skin in half the time of any existing ointment or salve.
EXPLICACIÓN DE LA INVENCIÓN EXPLANATION OF THE INVENTION
El producto en pomada para hematomas que la invención propone, permite alcanzar satisfactoriamente los objetivos anteriormente señalados, estando los detalles caracterizadores que lo hacen posible y que lo distinguen convenientemente recogidos en las reivindicaciones finales que se acompañan a la presente descripción. The ointment product for bruises proposed by the invention allows the objectives previously stated to be satisfactorily achieved, the characterizing details that make it possible and that distinguish it being conveniently included in the final claims that accompany this description.
De forma concreta, el producto en pomada para hematomas, que la presente invención propone, como se ha apuntado anteriormente, en una realización preferida, que comprende los ingredientes que se describen a continuación en las proporciones indicadas, para la obtención de 100 gramos: Specifically, the ointment product for bruises, which the present invention proposes, as indicated above, in a preferred embodiment, which comprises the ingredients described below in the indicated proportions, to obtain 100 grams:
Fitomenadiona............................... 48,33 ml Phytomenadione................................. 48.33 ml
Acido glicocólico............................. 0,25 ml Glycocholic acid................................ 0.25 ml
Hidróxido sódico............................. 0,27 ml Lecitina........................................... 0,30 ml Sodium hydroxide........................................ 0.27 ml Lecithin.......................................... 0.30 ml
Acido clorhídrico (al 25%).............. 0,25 ml Hydrochloric acid (25%)................ 0.25 ml
Agua esteril.................................... 0,60 ml Sterile water................................. 0.60 ml
Vaselina pura filante .................... 50 gramos Pure Vaseline threading .................... 50 grams
Todos estos ingredientes se mezclan homogéneamente, creándose una pomada de uso tópico, que reduce con rapidez los hematomas causados por traumatismos quirúrgicos o golpes. Su efecto es inmediato desde la primera aplicación. Y normaliza las pigmentaciones antiestéticas de la piel, de color amarillo parduzco o verdoso producidos por el hematoma. All these ingredients are mixed homogeneously, creating a topical ointment that quickly reduces bruising caused by surgical trauma or blows. Its effect is immediate from the first application. It also normalizes unsightly skin pigmentation, brownish yellow or greenish, caused by the bruise.
La fitomenadiona es la forma sintética de vitamina Ki liposoluble, prácticamente insoluble en agua, pero miscible con ácidos grasos y es el ingrediente activo, el acido glicocólico es un agente emulsionante, el hidróxido sódico para reducir la acidez del producto final, la lecitina es un aditivo E-322, emulsionante y antioxidante, el ácido clorhídrico al 25% , agua estéril sin contaminación y la vaselina pura filante que es una mezcla purificada de hidrocarburos semisólidos obtenidos del petróleo, decolorada totalmente, es un agente oclusivo y emoliente que promueve la retención de agua debido a su hidrofobicidad. Phytomenadione is the synthetic form of fat-soluble vitamin Ki, practically insoluble in water but miscible with fatty acids and is the active ingredient, glycocholic acid is an emulsifying agent, sodium hydroxide to reduce the acidity of the final product, lecithin is an additive E-322, emulsifier and antioxidant, 25% hydrochloric acid, sterile water without contamination and pure Vaseline which is a purified mixture of semi-solid hydrocarbons obtained from petroleum, completely decolorized, is an occlusive and emollient agent that promotes water retention due to its hydrophobicity.
REALIZACIÓN PREFERENTE DE LA INVENCIÓN PREFERRED EMBODIMENT OF THE INVENTION
En una realización preferida se utiliza fitomenadiona, ácido glicocólico, hidróxido de sodio, lecitina, ácido clorhídrico al 25%, agua estéril sin contaminación y se mezcla homogéneamente con vaselina pura filante, en las proporciones siguientes para la obtención de 100 gramos de pomada: In a preferred embodiment, phytonadione, glycocholic acid, sodium hydroxide, lecithin, 25% hydrochloric acid, sterile water without contamination are used and mixed homogeneously with pure threading Vaseline, in the following proportions to obtain 100 grams of ointment:
Fitomenadiona.......................................................................... 48,33 ml Acido glicocólico........................................................................ 0,25 ml Hidróxido sódico........................................................................ 0,27 ml Lecitina...................................................................................... 0,30 ml Acido clorhídrico (al 25% )......................................................... 0,25 ml Agua esteril................................................................................ 0,60 ml Vaselina pura filante................................................................. 50 gramos Phytomenadione................................................ ......................... 48.33 ml Glycocholic acid................... .................................................. ...0.25 ml Sodium hydroxide.............................................. .................................. 0.27 ml Lecithin.............. .................................................. .................... 0.30 ml Hydrochloric acid (25%).................. ........................................ 0.25 ml Sterile water.... .................................................. ................................. 0.60 ml pure filament Vaseline................. ................................................ 50 grams
Se dispone en un recipiente de 50 gramos de vaselina pura filante que es mezclada homogéneamente con todos los componentes citados anteriormente, obteniéndose un producto de pomada que se deja reposar unos minutos a temperatura ambiente antes de ser envasada. It is placed in a 50 gram container of pure, thready Vaseline which is mixed homogeneously with all the components mentioned above, obtaining an ointment product that is left to rest for a few minutes at room temperature before being packaged.
Descrita suficientemente la naturaleza de la presente invención, así como la manera de ponerla en práctica, se hace constar que, dentro de su esencialidad, podrá ser llevada a la práctica en otras formas de realización que difieran en detalle de la indicada a título de ejemplo, siempre que no se altere, cambie o modifique lo fundamental. Having sufficiently described the nature of the present invention, as well as the manner of putting it into practice, it is noted that, within its essence, it may be put into practice in other forms of embodiment that differ in detail from that indicated by way of example, provided that the fundamental aspect is not altered, changed or modified.
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES202430499U ES1311367Y (en) | 2024-03-14 | 2024-03-14 | OINTMENT PRODUCT FOR BRUISES |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES202430499U ES1311367Y (en) | 2024-03-14 | 2024-03-14 | OINTMENT PRODUCT FOR BRUISES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES1311367U true ES1311367U (en) | 2024-10-30 |
| ES1311367Y ES1311367Y (en) | 2025-01-27 |
Family
ID=93254356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES202430499U Active ES1311367Y (en) | 2024-03-14 | 2024-03-14 | OINTMENT PRODUCT FOR BRUISES |
Country Status (1)
| Country | Link |
|---|---|
| ES (1) | ES1311367Y (en) |
-
2024
- 2024-03-14 ES ES202430499U patent/ES1311367Y/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES1311367Y (en) | 2025-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018296678B2 (en) | Stable cannabinoid compositions | |
| WO2021175453A1 (en) | Composition comprising an aventhramide or an analogue thereof with improved stability | |
| RU2640915C2 (en) | Flavonoid-based composition for pharmaceutical, dietary or cosmetic application with enhanced antioxidant action | |
| IL261774A (en) | Preparations for the treatment of skin problems | |
| CA2156623C (en) | Skin care composition | |
| Takahashi et al. | Toxicological Studies on Procyanidin B-2 for Extern? al Application as a Hair Growing Agent | |
| US5552158A (en) | Skin care composition | |
| Kumar et al. | Antioxidants in Skin Disorders | |
| ES1311367U (en) | OINTMENT PRODUCT FOR BRUISES (Machine-translation by Google Translate, not legally binding) | |
| EP3773466A1 (en) | Topical composition comprised of cod liver oil for treating wounds and skin disorders | |
| DE202005007603U1 (en) | Composition for oral or topical administration, e.g. as a dietary supplement or dietetic food, shower gel, body lotion, cream or care concentrate, comprises argan oil and nigella oil | |
| US11779527B2 (en) | Useful compositions for the cosmetic treatment of oily skin | |
| Weisberg et al. | The foundation for the use of olive oil in skin care and botanical cosmeceuticals | |
| FI129488B (en) | Salve composition, method of manufacture and use of the composition | |
| ES2420080B1 (en) | Synergistic combination of flavonoids and vitamin C | |
| NZ237771A (en) | Cosmetic compositions, particularly for acne treatment, containing an extract of zygophyllaceae of the genus larrea | |
| KR102418845B1 (en) | Powder cosmetic composition comprising vitamin c | |
| US20200188351A1 (en) | Topical hair and skin formulation | |
| KR102396785B1 (en) | Antioxidant complex and composition forming the same | |
| RU2319478C1 (en) | Cosmetic agent | |
| Hettiarachchi et al. | Coconut oil: unlocking its hidden potential–from health powerhouse to ground-breaking innovations | |
| BR102022015198A2 (en) | VEGAN PHYTOCOSMETICS FORMULATION FOR DIAPER DREAMS DEVELOPED WITH ESSENTIAL FATTY ACIDS (AGE) | |
| BR102022002911A2 (en) | COMPOSITION, PROCESS AND PREPARATION OF A COSMETICS CONTAINING EXTRACTS FROM CAMU-CAMU (MYRCIARIA DUBIA) FRUIT PEEL WITH ANTIOXIDANT ACTION | |
| Dilmaçünal | Medicinal value of some horticultural crops | |
| RU2677661C1 (en) | Active cosmetic additive |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CA1K | Utility model application published |
Ref document number: 1311367 Country of ref document: ES Kind code of ref document: U Effective date: 20241030 |
|
| FG1K | Utility model granted |
Ref document number: 1311367 Country of ref document: ES Kind code of ref document: Y Effective date: 20250121 |